Article
Nintedanib ameliorates experimental pulmonary arterial hypertension via inhibition of…
bioRxiv · 2019 · Takeo Tsutsumi
Key facts
| Title | Nintedanib ameliorates experimental pulmonary arterial hypertension via inhibition of endothelial mesenchymal transition and smooth muscle cell proliferation |
|---|---|
| First author | Takeo Tsutsumi |
| Journal | bioRxiv |
| Published | Mar 20, 2019 |
| DOI | 10.1101/584110 |
| Devices mentioned | K040782, K800552, K843077, K843710, K853723, K860811, K862004, K874160, K874609, K912581, K915561, K915840 and 13 more |
| Product codes mentioned | DGC, EPT, GCJ, GCT, GEX, HET, HJO, HLI, HLQ, HQF, JAK, KKX and 1 more |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1